0
     

Report Added
Report already added
Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity

Europe clinical trials market was valued at $10,471.1 million in 2021 and will grow by 6.2% annually over 2021-2031, driven by the increasing number of clinical trials and increase in demand for novel therapies, rising prevalence on chronic diseases such as cancer and diabetes, the outbreak of tropical and infectious diseases such as COVID-19, and the increase in government initiatives and R&D investments.

Highlighted with 39 tables and 79 figures, this 142-page report “Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe clinical trials market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
•Market Structure
•Growth Drivers
•Restraints and Challenges
•Emerging Product Trends & Market Opportunities
•Porter’s Fiver Forces
The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe clinical trials market in every aspect of the classification from perspectives of Product Category, Phase, Design, Service Type, Indication, End User, and Country.

Based on Product Category, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Trials of Drugs
oSmall Molecule Drugs
oVaccines
oCell & Gene Therapy
oOther Drugs
•Trials of Devices
•Trials of Procedures

Based on Phase, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Phase I
•Phase II
•Phase III
•Phase IV

By Design, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Interventional Studies
oRandomized Control Trial
oAdaptive Clinical Trial
oNon-randomized Control Trial
•Observational Studies
oCohort Study
oCase Control Study
oCross Sectional Study
oEcological Study
•Expanded Access Trials

By Service Type, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Protocol Designing
•Site Identification
•Patient Recruitment
•Laboratory Services
•Bioanalytical Testing Services
•Clinical Trial Data Management Services
•Clinical Trial Supply & Logistic Services
•Decentralized Clinical Trial Services
•Medical Device Testing Services
•Other Clinical Trial Services

By Indication, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Oncology
•Infectious Diseases
•Cardiology
•Obesity
•Diabetes
•Neurology
•Immunology
•Pain Management
•Other Indications

By End User, the Europe market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
•Pharmaceutical and Biotechnological Companies
•Clinical Research Organizations
•Clinical Testing Laboratories
•Other End Users

Geographically, the following national/local markets are fully investigated:
•Germany
•UK
•France
•Spain
•Italy
•Russia
•Rest of Europe (further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Phase, Design, and Indication over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:
Accell Clinical Research LLC
Charles River Laboratory
ClinDatrix Inc
Clinipace
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
ICON PLC
IQVIA Holdings, Inc.
Laboratory Corporation of America
Novo Nordisk AS
PAREXEL International Corporation
Pfizer Inc.
Pharmaceutical Product Development LLC
PRA Health Sciences
Sanofi SA
SGS SA
Syneos Health Inc.
Wuxi AppTec Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents

1 Introduction7
1.1 Industry Definition and Research Scope7
1.1.1 Industry Definition7
1.1.2 Research Scope8
1.2 Research Methodology11
1.2.1 Overview of Market Research Methodology11
1.2.2 Market Assumption12
1.2.3 Secondary Data12
1.2.4 Primary Data12
1.2.5 Data Filtration and Model Design13
1.2.6 Market Size/Share Estimation14
1.2.7 Research Limitations15
1.3 Executive Summary16
2 Market Overview and Dynamics19
2.1 Market Size and Forecast19
2.1.1 Impact of COVID-19 on World Economy21
2.1.2 Impact of COVID-19 on the Market23
2.2 Major Growth Drivers25
2.3 Market Restraints and Challenges32
2.4 Emerging Opportunities and Market Trends35
2.5 Porter’s Fiver Forces Analysis39
3 Segmentation of Europe Market by Product Category43
3.1 Market Overview by Product Category43
3.2 Trials of Drugs45
3.2.1 Small Molecule Drugs46
3.2.2 Vaccines47
3.2.3 Cell & Gene Therapy48
3.2.4 Other Drugs49
3.3 Trials of Devices50
3.4 Trials of Procedures51
4 Segmentation of Europe Market by Phase52
4.1 Market Overview by Phase52
4.2 Phase I54
4.3 Phase II55
4.4 Phase III56
4.5 Phase IV57
5 Segmentation of Europe Market by Design58
5.1 Market Overview by Design58
5.2 Interventional Studies60
5.2.1 Randomized Control Trial62
5.2.2 Adaptive Clinical Trial63
5.2.3 Non-randomized Control Trial64
5.3 Observational Studies65
5.3.1 Cohort Study67
5.3.2 Case Control Study68
5.3.3 Cross Sectional Study69
5.3.4 Ecological Study70
5.4 Expanded Access Trials71
6 Segmentation of Europe Market by Service Type72
6.1 Market Overview by Service Type72
6.2 Protocol Designing74
6.3 Site Identification75
6.4 Patient Recruitment76
6.5 Laboratory Services77
6.6 Bioanalytical Testing Services78
6.7 Clinical Trial Data Management Services79
6.8 Clinical Trial Supply & Logistic Services80
6.9 Decentralized Clinical Trial Services81
6.10 Medical Device Testing Services82
6.11 Other Clinical Trial Services83
7 Segmentation of Europe Market by Indication84
7.1 Market Overview by Indication84
7.2 Oncology86
7.3 Infectious Diseases87
7.4 Cardiology88
7.5 Obesity89
7.6 Diabetes90
7.7 Neurology91
7.8 Immunology92
7.9 Pain Management93
7.10 Other Indications94
8 Segmentation of Europe Market by End User95
8.1 Market Overview by End User95
8.2 Pharmaceutical and Biotechnological Companies97
8.3 Clinical Research Organizations98
8.4 Clinical Testing Laboratories99
8.5 Other End Users100
9 European Market 2021-2031 by Country101
9.1 Overview of European Market101
9.2 Germany104
9.3 U.K.106
9.4 France108
9.5 Spain110
9.6 Italy112
9.7 Russia114
9.8 Rest of European Market116
10 Competitive Landscape118
10.1 Overview of Key Vendors118
10.2 New Product Launch, Partnership, Investment, and M&A122
10.3 Company Profiles123
Accell Clinical Research LLC123
Charles River Laboratory125
ClinDatrix Inc126
Clinipace127
Eli Lilly and Company128
F. Hoffmann-La Roche Ltd.129
ICON PLC130
IQVIA Holdings, Inc.131
Laboratory Corporation of America132
Novo Nordisk AS133
PAREXEL International Corporation134
Pfizer Inc.135
Pharmaceutical Product Development LLC136
PRA Health Sciences137
Sanofi SA138
SGS SA139
Syneos Health Inc.140
Wuxi AppTec Inc.141
RELATED REPORTS142

List of Tables:

Table 1. Snapshot of Europe Clinical Trials Market in Balanced Perspective, 2021-203117
Table 2. Total Number of Registered Clinical Studies Worldwide, 2010-202120
Table 3. World Economic Outlook, 2021-203122
Table 4. World Health Spending by Region, $ bn, 2013-202031
Table 5. Main Product Trends and Market Opportunities in Europe Clinical Trials Market35
Table 6. Europe Clinical Trials Market by Product Category, 2021-2031, $ mn43
Table 7. Europe Clinical Trials Market: Trials of Drugs by Drug Type, 2021-2031, $ mn45
Table 8. Europe Clinical Trials Market by Phase, 2021-2031, $ mn52
Table 9. Europe Clinical Trials Market by Design, 2021-2031, $ mn58
Table 10. Europe Clinical Trials Market: Interventional Studies by Segment, 2021-2031, $ mn61
Table 11. Europe Clinical Trials Market: Observational Studies by Segment, 2021-2031, $ mn66
Table 12. Europe Clinical Trials Market by Service Type, 2021-2031, $ mn72
Table 13. Europe Clinical Trials Market by Indication, 2021-2031, $ mn84
Table 14. Europe Clinical Trials Market by End User, 2021-2031, $ mn95
Table 15. Europe Clinical Trials Market by Country, 2021-2031, $ mn103
Table 16. Germany Clinical Trials Market by Phase, 2021-2031, $ mn105
Table 17. Germany Clinical Trials Market by Design, 2021-2031, $ mn105
Table 18. Germany Clinical Trials Market by Indication, 2021-2031, $ mn105
Table 19. U.K. Clinical Trials Market by Phase, 2021-2031, $ mn107
Table 20. U.K. Clinical Trials Market by Design, 2021-2031, $ mn107
Table 21. U.K. Clinical Trials Market by Indication, 2021-2031, $ mn107
Table 22. France Clinical Trials Market by Phase, 2021-2031, $ mn109
Table 23. France Clinical Trials Market by Design, 2021-2031, $ mn109
Table 24. France Clinical Trials Market by Indication, 2021-2031, $ mn109
Table 25. Spain Clinical Trials Market by Phase, 2021-2031, $ mn111
Table 26. Spain Clinical Trials Market by Design, 2021-2031, $ mn111
Table 27. Spain Clinical Trials Market by Indication, 2021-2031, $ mn111
Table 28. Italy Clinical Trials Market by Phase, 2021-2031, $ mn113
Table 29. Italy Clinical Trials Market by Design, 2021-2031, $ mn113
Table 30. Italy Clinical Trials Market by Indication, 2021-2031, $ mn113
Table 31. Russia Clinical Trials Market by Phase, 2021-2031, $ mn115
Table 32. Russia Clinical Trials Market by Design, 2021-2031, $ mn115
Table 33. Russia Clinical Trials Market by Indication, 2021-2031, $ mn115
Table 34. Clinical Trials Market in Rest of Europe by Country, 2021-2031, $ mn117
Table 35. Percentage of Registered Studies by Location (as of February 24, 2022)120
Table 36. Percentage of Recruiting Studies by Location (as of February 24, 2022)120
Table 37. Accell Clinical Research LLC: Company Snapshot123
Table 38. Accell Clinical Research LLC: Business Segmentation124
Table 39. Accell Clinical Research LLC: Product Portfolio124

Report Title: Europe Clinical Trials Market 2021-2031 by Product Category (Drugs, Devices, Procedures), Phase (I, II, III, IV), Design (Interventional, Observational, Expanded Access), Service Type (Site Identification, Lab Services, Supply & Logistic, Decentralized Services), Indication (Oncology, Infectious Diseases, Cardiology, Obesity, Diabetes, Neurology), End User, and Country: Trend Forecast and Growth Opportunity


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW